|143.01||+1.85||+1.31%||Vol 26.26K||1Y Perf -11.09%|
|Apr 9th, 2020 09:33|
|2.84 2.01%||0.84 0.60%|
|Target Price||185.54||Analyst Rating||Strong Buy 1.54|
|Potential %||31.44||Finscreener Ranking||★+ 43.89|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 46.75|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★+ 48.45|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||13.89B||Earnings Rating||Sell|
|Price Range Ratio 52W %||45.75||Earnings Date||29th Apr 2020|
Today's Price Range
5 Year PE Ratio Range
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
Return on Equity (5Y Avg)
ROE last 12 Months
Return on Assets (5Y Avg)
ROA last 12 Months
Return on Capital (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||29th Apr 2020|
|Estimated EPS Next Report||2.35|
|EPS Growth Next 5 Years %||5.30|
|Avg. Weekly Volume||1.12M|
|Avg. Monthly Volume||1.37M|
|Avg. Quarterly Volume||1.05M|
Laboratory Corporation of America Holdings (NYSE: LH) closed at 141.16 per share at the end of the most recent trading day (a 5.78% change compared to the prior day closing price) with a volume of 1.13M shares and market capitalization of 13.89B. Is a component of S&P 500, Russell 1000 indexes and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61000 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.
The one-year performance of Laboratory Corporation of America Holdings stock is -11.09%, while year-to-date (YTD) performance is -16.56%. LH stock has a five-year performance of 11.97%. Its 52-week range is between 98.02 and 196.36, which gives LH stock a 52-week price range ratio of 45.75%
Laboratory Corporation of America Holdings currently has a PE ratio of 13.60, a price-to-book (PB) ratio of 1.45, a price-to-sale (PS) ratio of 1.40, a price to cashflow ratio of 7.70, a PEG ratio of 2.32, a ROA of 4.87%, a ROC of 7.24% and a ROE of 11.46%. The company’s profit margin is 7.29%, its EBITDA margin is 16.60%, and its revenue ttm is $8.76 Billion , which makes it $90.25 revenue per share.
Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.35 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 29th Apr 2020.
The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.54), with a target price of $185.54, which is +31.44% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 30.92, ATR14 : 11.80, CCI20 : 114.41, Chaikin Money Flow : 0.04, MACD : -8.48, Money Flow Index : 52.42, ROC : 19.86, RSI : 51.74, STOCH (14,3) : 91.00, STOCH RSI : 1.00, UO : 53.81, Williams %R : -9.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), David P. King (Option Excercise at a value of $0), David P. King (Sold 60 354 shares of value $9 982 432 ), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Glenn A. Eisenberg (Sold 15 563 shares of value $2 657 230 ), Jean-Luc Belingard (Option Excercise at a value of $239 289), Jean-Luc Belingard (Sold 26 479 shares of value $5 024 750 ), Kerrii B. Anderson (Option Excercise at a value of $495 363), Kerrii B. Anderson (Sold 5 700 shares of value $973 810 ), Lance V. Berberian (Option Excercise at a value of $0), Lance V. Berberian (Sold 11 804 shares of value $2 004 344 ), Lisa J. Uthgenannt (Option Excercise at a value of $322 060), Lisa J. Uthgenannt (Sold 6 466 shares of value $1 071 743 ), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 296 shares of value $55 091 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $0), Peter J. Wilkinson (Sold 297 shares of value $56 326 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert E. Mittelstaedt (Option Excercise at a value of $238 354), Robert E. Mittelstaedt (Sold 3 700 shares of value $615 310 ), Robert Sanders Williams (Option Excercise at a value of $0), Robert Sanders Williams (Sold 2 227 shares of value $393 832 ), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 5 338 shares of value $949 769 )
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.